BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17136494)

  • 1. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death.
    Nakano K; Saito K; Mine S; Matsushita S; Tanaka Y
    Apoptosis; 2007 Jan; 12(1):45-54. PubMed ID: 17136494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death.
    Watanabe N; Arase H; Kurasawa K; Iwamoto I; Kayagaki N; Yagita H; Okumura K; Miyatake S; Saito T
    Eur J Immunol; 1997 Aug; 27(8):1858-64. PubMed ID: 9295019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function.
    Cui H; Sherr DH; el-Khatib M; Matsui K; Panka DJ; Marshak-Rothstein A; Ju ST
    Cell Immunol; 1996 Feb; 167(2):276-84. PubMed ID: 8603437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH; Lengl-Janssen B; Kabelitz D; Janssen O
    Cell Immunol; 1997 Oct; 181(1):93-100. PubMed ID: 9344501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
    Kaser A; Nagata S; Tilg H
    Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells.
    Tóth R; Szegezdi E; Reichert U; Bernardon JM; Michel S; Ancian P; Kis-Tóth K; Macsári Z; Fésüs L; Szondy Z
    Eur J Immunol; 2001 May; 31(5):1382-91. PubMed ID: 11465095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
    Daniel PT; Oettinger U; Mapara MY; Bommert K; Bargou R; Dörken B
    Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired apoptosis and immune senescence - cause or effect?
    Hsu HC; Scott DK; Mountz JD
    Immunol Rev; 2005 Jun; 205():130-46. PubMed ID: 15882350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis.
    Eischen CM; Williams BL; Zhang W; Samelson LE; Lynch DH; Abraham RT; Leibson PJ
    J Immunol; 1997 Aug; 159(3):1135-9. PubMed ID: 9233606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
    Liu WH; Cheng YC; Chang LS
    J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
    Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
    Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
    Liu WH; Chang LS
    Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Fas and FasL in Taiwan cobra phospholipase A2-treated human neuroblastoma SK-N-SH cells through ROS- and Ca2+-mediated p38 MAPK activation.
    Chen KC; Kao PH; Lin SR; Chang LS
    J Cell Biochem; 2009 Jan; 106(1):93-102. PubMed ID: 19009558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
    Modiano JF; Sun J; Lang J; Vacano G; Patterson D; Chan D; Franzusoff A; Gianani R; Meech SJ; Duke R; Bellgrau D
    Clin Immunol; 2004 Jul; 112(1):54-65. PubMed ID: 15207782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of CD44 on rheumatoid synovial cells up-regulates VCAM-1.
    Fujii K; Tanaka Y; Hubscher S; Saito K; Ota T; Eto S
    J Immunol; 1999 Feb; 162(4):2391-8. PubMed ID: 9973520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas.
    Williams MS; Henkart PA
    J Immunol; 1996 Sep; 157(6):2395-402. PubMed ID: 8805638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential role of tyrosine phosphorylation in the induction of apoptosis in T cell clones via CD95 or the TCR/CD3-complex.
    Oberg HH; Lengl-Janssen B; Robertson MJ; Kabelitz D; Janssen O
    Cell Death Differ; 1997 Jul; 4(5):403-12. PubMed ID: 16465259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
    Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
    Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signaling.
    Bremer E; Abdulahad WH; de Bruyn M; Samplonius DF; Kallenberg CG; Armbrust W; Brouwers E; Wajant H; Helfrich W
    Immunol Lett; 2011 Aug; 138(2):161-8. PubMed ID: 21514322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation.
    Cui H; el-Khatib M; Sherr DH; Ettinger R; Sy MS; Marshak-Rothstein A; Ju ST
    Cell Immunol; 1996 Feb; 167(2):302-12. PubMed ID: 8603440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.